Risk of HIV acquisition among circumcised and uncircumcised young men with penile human papillomavirus infection

AIDS

Volumn 28, Issue 5, 2014, Pages 745-752

  Rositch, Anne F ^a,b   Mao, Lu ^c   Hudgens, Michael G ^c   Moses, Stephen ^d   Agot, Kawango ^e   Backes, Danielle M ^f   Nyagaya, Edith ^d   Snijders, Peter J F ^g   Meijer, Chris J L M ^g   Bailey, Robert C ^h   Smith, Jennifer S ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

^e IMPACT RESEARCH AND DEVELOPMENT ORGANIZATION   (Kenya)

^f BROWN UNIVERSITY   (United States)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cervical cancer; Co infection; HIV; Human papillomavirus; Kenya; Male circumcision; Vaccination

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA MULTIPLEX PCR ASSAY; CHLAMYDIA TRACHOMATIS; CIRCUMCISION; COHORT ANALYSIS; CONDOM; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FOLLOW UP; GENOTYPE; GONORRHEA; HAZARD RATIO; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HIV ELISA KIT; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; KENYA; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; POPULATION AND POPULATION RELATED PHENOMENA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SEROCONVERSION; SEXUAL BEHAVIOR; VIRAL CLEARANCE; VIRAL DISEASE ELISA KIT; YOUNG ADULT; ADOLESCENT; COMPLICATION; HIV INFECTIONS; PENIS DISEASE; RISK ASSESSMENT; TRANSMISSION; TREATMENT OUTCOME;

ADOLESCENT; CIRCUMCISION, MALE; COHORT STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; KENYA; MALE; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84898004677     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000092     Document Type: Article

References (29)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
3. Averbach SH, Gravitt PE, Nowak RG, Celentano DD, Dunbar MS, Morrison CS, et al. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS 2010; 24:1035-1042.
4. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010; 53:111-116.
5. Auvert B, Marais D, Lissouba P, Zarca K, Ramjee G, Williamson AL. High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers. Infect Dis Obstet Gynecol 2011; 2011:692012.
6. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, et al. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoSOne 2014; 5:e10094.
7. Tobian AA, Grabowski MK, Kigozi G, Redd AD, Eaton KP, Serwadda D, et al. Human papillomavirus clearance in men is associated with HIV acquisition and increased foreskin dendritic cell density in Rakai, Uganda. J Infect Dis 2013; 207 (11):1713-1722.
8. Smith JS, Moses S, Hudgens MG, Parker CB, Agot K, Maclean I, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 2010; 201:1677-1685.
9. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 2009; 23:1135-1142.
10. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
11. Gray RH, Serwadda D, Kong X, Makumbi F, Kigozi G, Gravitt PE, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis 2010; 201:1455-1462.
12. Smith JS, Backes DM, Hudgens MG, Bailey RC, Veronesi G, Bogaarts M, et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer 2010; 126:572-577.
13. Smith JS, Moses S, Hudgens MG, Agot K, Franceschi S, Maclean IW, et al. Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis 2007; 34:928-934.
14. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5R/6R PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40:779-787.
15. Snijders PJF, Van den Brule AJC, Jacobs MV, Pol RP, Meijer CJLM. HPV DNA detection and typing in cervical scrapes by general primer GP5R/6RPCR. In: Davy CE, Doorbar J,editors. Methods in molecular medicine: human papillomaviruses: methods and protocols Totowa: Humana Press; 2005. pp. 101-114.
16. Snappin SM, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 2005; 59:301-308.
17. Allison P. Survival analysis using SAS: a practical guide. 2nd ed. Cary, NC: SAS Institute; 2010.
18. Breslow N. Covariance analysis of censored survival data. Biometrics 1974; 30:89-99.
19. Hertz-Picciotto I, Rockhill B. Validity and efficiency of approximation methods for tied survival times in Cox regression. Biometrics 1997; 53:1151-1156.
20. Rositch AF, Hudgens MG, Backes DM, Moses S, Agot K, Nyagaya E, et al. Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men. J Infect Dis 2012; 206:669-677.
21. Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012; 26:2211-2222.
22. Lissouba P, Van de Perre P, Auvert B. Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect 2013; 89 (5):350-356.
23. Camargo M, Soto-De Leon S, Sanchez R, Munoz M, Vega E, Beltran M, et al. Detection by PCR of human papillomavirus in Colombia: comparison of GP5R/6Rand MY09/11 primer sets. J Virol Methods 2011; 178:68-74.
24. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.
25. Morris BJ, Wamai RG. Biological basis for the protective effect conferred by male circumcision against HIV infection. Int J STD AIDS 2012; 23:153-159.
26. Bailey RC, Plummer FA, Moses S. Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis 2001; 1:223-231.
27. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-1309.
28. Chen L, Jha P, Stirling B, Sgaier SK, Daid T, Kaul R, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One 2007; 2:e1001.
29. Rositch AF, Gravitt PE, Smith JS. Growing evidence that HPV infectionis associated with anincreasein HIV acquisition:exploring the issue of HPV vaccination. Sex Transm Infect 2013; 89:357.